Activity Stream
@moatrx
• 3 weeks ago
Posted a new blog:
US FABRY DISEASE Competitive Intelligence
US FABRY DISEASE Competitive Intelligence
Pegunigalsidase now challenges Fabrazyme's two-decade lead, while oral migalastat works for only 35 to 50% of Fabry patients.
Fabry disease is an X-linked...
